Status:

UNKNOWN

Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections

Lead Sponsor:

Benha University

Conditions:

Pain, Postoperative

Eligibility:

FEMALE

18-40 years

Phase:

NA

Brief Summary

The main objective of our study is to evaluate analgesic effect of intrathecal dexamethasone and dexmedetomidine in elective caesarean sections

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )
  • Elective cesarean section under spinal anaesthesia
  • Gestational age \> 37 weeks
  • BMI less than 30 kg/m2

Exclusion

  • Patient refusal
  • unable to give consent
  • age \< 18 or \> 40
  • BMI more than 30 kg/m2
  • known allergy to the study medication
  • coagulopathies or on anticoagulant medications
  • diabetic neuropathy
  • patients with psychiatric disorders

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 30 2021

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT04697745

Start Date

March 1 2021

End Date

May 30 2021

Last Update

January 6 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections | DecenTrialz